Keyword: Oligonucleotides

News

Bachem Secures Major Peptide Contracts

22.09.2022 -

Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has announced the signing of two major contracts for supplying large volumes of...

Chemistry & Life Sciences

Expanding Into Oligonucleotides

15.04.2022 -

The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this...

Chemistry & Life Sciences

Expanding Into Oligonucleotides

04.12.2020 -

The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this...

News

WuXi STA and Regulus in Oligonucleotide Synthesis Pact

26.02.2018 - Two drug development specialists based in the US state of California, STA Pharmaceutical, part of the WuXi AppTec group, and Regulus Therapeutics, have agreed to collaborate on...

Trends in Chemical & Pharmaceutical Research

26.09.2016 - Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...